Financials

  • Market Capitalization 487.13 M
  • Employee 246
  • Founded 2013
  • CEO N/A
  • Website www.arvinas.com
  • Headquarter Delaware, United States
  • FIGI BBG00LW7YK82
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.4
Rapporto prezzo/fatturato
3.2

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2852
ALT
Altimmune, Inc. - Common Stock
2.56 USD-1.92%-5.19%-21.71%-34.69%497.97 M USD
2870
NGNE
Neurogene Inc. - Common Stock
24.44 USD-7.42%-8.22%-31.96%-16.93%489.08 M USD
2881
ALLO
Allogene Therapeutics, Inc. - Common Stock
1.40 USD-4.11%-6.67%-21.79%+13.82%483.69 M USD
2890
RZLT
Rezolute, Inc. - Common Stock
4.87 USD0.00%+4.96%+16.51%-37.96%471.04 M USD

Notizie